ICON plc
Update in progressICLR (NasdaqGS)
- Company RatingNeutralCompany RatingCombines sentiment and sustainability signals into an overall assessment of the company.Great · Good · Neutral · At Risk · Poor
- SectorHealthcare
- IndustryDiagnostics & Research
ICON Public Limited Company is a global clinical research organization (CRO) delivering outsourced development and commercialization services. It supports programs from compound selection through Phase I–IV trials, peri- and post‑approval activities, data solutions, and site and patient access. It offers trial management, consulting, staffing, labs, adaptive and decentralized trials, and real‑world data. Headquartered in Dublin, founded 1989, it serves pharma, biotech, medical devices, and public health, with an alliance with Advarra to create a connected trial site network.
Company score
- Sentiment
- -0.24
- SentimentMeasures the overall tone of recent coverage and discussion about the company.−10 negative · 0 neutral · +10 positive
- Environment
- 0.05
- EnvironmentAssesses the company’s environmental impact, risks, and sustainability practices.−10 negative · 0 neutral · +10 positive
- Social
- 0.18
- Governance
- -0.51
- GovernanceAssesses leadership, accountability, transparency, and business ethics.−10 negative · 0 neutral · +10 positive
- Sustainability
- -0.04
- SustainabilityCombines environmental, social, and governance signals into an overall sustainability score.−10 negative · 0 neutral · +10 positive
- Impact Score
- -0.14
- Impact ScoreCombines sentiment and sustainability performance into an assessment of the company’s overall impact.−10 negative · 0 neutral · +10 positive
Sort by
Order by
Timeframe
No news articles are available for this company yet.
Unable to load company news.
Loading more news
You're all caught up!